© The Author 2006. Published by Oxford University Press.
BRIEF COMMUNICATION |
Delayed Versus Immediate Surgical Intervention and Prostate Cancer Outcome
Affiliations of authors: Departments of Urology (CW, BJT, PL, HBC) and Pathology (JIE), Johns Hopkins University School of Medicine, James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD
Correspondence to: H. Ballentine Carter, MD, Department of Urology, Marburg 403, Johns Hopkins School of Medicine, 600 N. Wolfe St., Baltimore, MD 21287 (e-mail: hcarter{at}jhmi.edu).
For prostate cancer patients with small, lower-grade tumors, expectant management with delayed surgical intervention (active surveillance) is a rarely used therapeutic option because the opportunity for cure may be lost. We compared outcomes of 38 patients with small, lower-grade prostate cancer in an expectant management program who underwent delayed surgical intervention at a median of 26.5 months (95% confidence interval [CI] = 17 to 32 months; range = 12.0–73.0 months) after diagnosis with 150 similar patients who underwent immediate surgical intervention at a median of 3.0 months (95% CI = 2 to 4 months; range = 1.0–9.0 months) after diagnosis. Noncurable cancer was defined as adverse pathology associated with a less than 75% chance of remaining disease-free for 10 years after surgery. Noncurable cancer was diagnosed in nine (23%) of the 38 patients in the delayed intervention cohort and in 24 (16%) of the 150 men in the immediate intervention group. After adjusting for age and prostate-specific antigen (PSA) density (i.e., PSA value divided by prostate volume) in a Mantel–Haenszel analysis, the risks of noncurable cancer associated with delayed and immediate intervention did not differ statistically significantly (relative risk = 1.08, 95% CI = 0.55 to 2.12; P = .819, two-sided Cochran–Mantel–Haenszel statistic). Age, PSA, and PSA density were all statistically significantly associated with the risk of noncurable cancer (P = .030, .013, and .008, respectively; two-sided chi-square test). Thus, delayed prostate cancer surgery for patients with small, lower-grade prostate cancers does not appear to compromise curability.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. G. Sanda and I. D. Kaplan A 64-Year-Old Man With Low-Risk Prostate Cancer: Review of Prostate Cancer Treatment JAMA, May 27, 2009; 301(20): 2141 - 2151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Barry, D. S. Kaufman, and C.-L. Wu Case 15-2008 -- A 55-Year-Old Man with an Elevated Prostate-Specific Antigen Level and Early-Stage Prostate Cancer N. Engl. J. Med., May 15, 2008; 358(20): 2161 - 2168. [Full Text] [PDF]
|
|
|
|
|
|
P. C. Walsh, T. L. DeWeese, and M. A. Eisenberger Localized Prostate Cancer N. Engl. J. Med., December 27, 2007; 357(26): 2696 - 2705. [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Miller, S. B. Gruber, B. K. Hollenbeck, J. E. Montie, and J. T. Wei Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst, August 16, 2006; 98(16): 1134 - 1141. [Abstract] [Full Text] [PDF]
|
|